• 1

    American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care. .Diabetes Care 22::1354. ,1999. .

  • 2

    Drug treatment protocols: management of foot ulcers in patients with diabetes. .J Am Pharm Assoc (Wash) 40::467. ,2000. .

  • 3

    Bergstrom N, Bennett MA, Carlson CE, et al: Clinical Practice Guideline Number 15: Treatment of Pressure Ulcers. AHCPR publication 95-0652. US Dept of Health and Human Services, Agency for Health Care Policy and Research, Rockville, MD, 1994..

  • 4

    Dorland’s Illustrated Medical Dictionary, 28th Ed, WB Saunders, Philadelphia, 1994..

  • 5

    Wound Consultants Inc: WCI Manual, Denver, 1998..

  • 6

    Goebel RH, Goebel MR: Clinical practice guidelines for pressure ulcer prevention can prevent malpractice lawsuits in older patients. .J Wound Ostomy Continence Nurs. 26::175. ,1999. .

    • PubMed
    • Search Google Scholar
    • Export Citation

Standardizing Wound Treatment Procedures for Advanced Technologies

Gerit D. Mulder DPM, MS1
View More View Less
  • 1 Director of Research and Education, Clinical Director, University of California San Diego Medical Center, Regional Burn Center/Wound Treatment and Research Center, 200 W Arbor Dr 8896, San Diego, CA 92103-8896.
Restricted access

New drugs and tissue replacements are currently being approved and integrated into treatment regimens for chronic wounds. This article focuses on a standardized procedure for the use of specific growth factor, a recombinant human platelet-derived growth factor (rhPDGF-BB) manufactured for topical administration. The recommendations made in this article may not reflect product recommendations made by the manufacturer of the drug. Clinicians must be able to support any off-label indication for use of a product. (J Am Podiatr Med Assoc 92(1): 7-11, 2002)